McGee v. Target Corporation

District Court, D. Nevada·Decided June 3, 2023·No. 2:20-cv-00345·Unknown

Opinion

* * *

LELA MCGEE, Case No. 2:20-cv-00345-KJD-DJA

Plaintiff, ORDER

v.

Defendant.

Presently before the Court are Plaintiff’s four Trial Briefs (#69/70/71/72). However, the Court interprets them to be Motions in Limine. Defendant responded in opposition (#84/85/86/87). I. Factual and Procedural Background This is a negligence action arising from a slip-and-fall on March 25, 2019. The Plaintiff, Lela McGee (“McGee”) visited Defendant Target Corporation’s (“Target”) store in Las Vegas, Nevada, where McGee tripped and fell. (#27, at 14). McGee alleges that her foot became lodged between the display end cap and a metal end cap guard that was bolted to the floor and attached to a counter displaying earphones. (#28, at 3-4). McGee alleges that she suffered injuries to her shin, ankle, neck, and back, and that Target is responsible. McGee brings four motions in limine to exclude (1) evidence of McGee’s marijuana use; (2) arguments regarding McGee’s pain symptoms and Paget’s disease; (3) arguments regarding McGee’s economic damages and Carpel Tunnel Syndrome; and (4) arguments regarding unrelated incidents. II. Legal Standard A motion in limine is a procedural mechanism made in advance to limit testimony or evidence in a particular area” and is “entirely within the discretion of the Court.” Diamond X Ranch, LLC v. Atlantic Richfield Co., No. 3:13-cv-00570-MMD-WGC, 2018 WL 2127734, at *1 (D. Nev. May 8, 2018). A “motion in limine should not be used to resolve factual disputes or weigh evidence.” IGT v. Alliance Gaming Corp., No. 2:04-cv-1676-RCJ-RJJ, 2008 WL 7084605, at *2 (D. Nev. Oct. 21, 2008). “To exclude evidence on a motion in limine, ‘the evidence must be inadmissible on all potential grounds.’” Diamond X Ranch, 2018 WL 2127734, at *1 (quoting Indiana Ins. Co. v. General Elec. Co., 326 F.Supp.2d 844, 846 (N.D. Ohio 2004)). “Unless evidence meets this high standard, evidentiary rulings should be deferred until trial so that questions of foundation, relevancy and potential prejudice may be resolved in proper context.” Sims, 550 F. Supp. 3d, at 912, (quoting Hawthorne Partners v. AT&T Tech., Inc., 831 F. Supp. 1398, 1400 (N.D. Ill. 1993)). “Irrelevant evidence is not admissible.” Fed. R. Evid. (“Rule”) 402. “Evidence is relevant if: (a) it has any tendency to make a fact more or less probable than it would be without the evidence; and (b) the fact is of consequence in determining the action.” Rule 401. “The Court may exclude relevant evidence if its probative value is substantially outweighed by a danger of one or more of the following: unfair prejudice, confusing the issues, misleading the jury, undue delay, wasting time, or needlessly presenting cumulative evidence.” Rule 403. Rule 702 permits a “witness who is qualified as an expert by knowledge, skill, experience, training, or education [to] testify in the form of an opinion or otherwise if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.” The Supreme Court gave expanded direction on Rule 702 in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). In Daubert, the Court held that Rule 702 imposed “a special obligation upon a trial judge to ‘ensure that any and all scientific testimony… is not only relevant, but reliable.’” See Kumho Tire Co. v. Carmichael, 526 U.S. 137 (1999). The Court expanded this gatekeeping obligation to all expert testimony. Id. at 147. Daubert “established that, faced with a proffer of expert scientific testimony, the trial judge, in making the initial determination whether to admit the evidence, must determine whether the expert’s testimony reflects (1) “scientific knowledge,” and (2) will assist the trier of fact to understand or determine a material fact at issue.” Daubert, 509 U.S. at 592. The “focus must be solely on principles and methodology, not on the conclusions that they generate.” Id. at 595. “Vigorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof are the traditional and appropriate means of attacking shaky but admissible evidence.” Id. at 596. III. Analysis A. McGee’s Marijuana Use McGee argues that evidence of her marijuana use for pain management is not relevant because it is not a fact of consequence in determining critical issues in this litigation. (#69, at 4). McGee was questioned during a deposition about her history of marijuana use and responded that for the last 25 years, she has smoked marijuana three or four times a week to help manage her back pain. (#84, at 3-4). McGee seeks to exclude any mention of this during trial because it “does not make it more or less likely that she was injured when she slipped and fell at Defendant’s store, yet such evidence has significant potential to cause unfair prejudice and bias in the jury….” (#69, at 3). Target argues that this testimony is relevant to “causation, injuries, and damages” and that “it will be used to impeach Plaintiff’s treating physicians who did not consider the longstanding degenerative conditions and use of marijuana to mask the pain for 25 years.” (#84, at 5). The Court agrees. At issue in this case is whether Target was negligent. McGee is alleging that Target’s negligence caused injuries to her back. Whether or not McGee had preexisting back pain is surely relevant and probative of causation. Therefore, evidence of McGee’s marijuana use will be admissible during trial and McGee’s motion in limine in denied. B. McGee’s Pain Symptoms and Paget’s Disease McGee argues that evidence of her back pain and symptoms being connected to Paget’s disease1 should not be admissible. (#70). McGee asserts that Target “failed to provide any expert

Free access — add to your briefcase to read the full text and ask questions with AI

McGee v. Target Corporation, (D. Nev. 2023).

McGee v. Target Corporation (McGee v. Target Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Hawthorne Partners v. AT & T TECHNOLOGIES, INC.
831 F. Supp. 1398 (N.D. Illinois, 1993)
Indiana Insurance v. General Electric Co.
326 F. Supp. 2d 844 (N.D. Ohio, 2004)